High prevalence of primary aldosteronism in the Tayside hypertension clinic population

Journal of Human Hypertension

Volumn 14, Issue 5, 2000, Pages 311-315

  Lim, Pitt O ^a   Dow, E ^b   Brennan, G ^a   Jung, R T ^a   MacDonald, T M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Aldosterone to renin ratio; Hypertension; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXASOZIN; FLUDROCORTISONE; GLUCOCORTICOID; POTASSIUM CHLORIDE; RENIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD PRESSURE REGULATION; FEMALE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PLASMA RENIN ACTIVITY; SALT LOADING;

EID: 0034105028     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001013     Document Type: Article

References (28)

1. Sinclair AM et al. Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987; 147: 1289-1293.
2. Conn JW. Plasma renin activity in primary aldosteronism. JAMA 1964; 90: 222-225.
3. Gordon RD et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315-318.
4. Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'? Aust N Z J Med 1996; 26: 533-538.
5. Anis Anwar Y, White WB, Mansoor GA, Tendler BE. Hyperaldosteronism is a common cause of secondary hypertension missed by primary care physicians and associated with normokalaemia. Am J Hypertens 1998; 11 (4 part 2): 199A (M001).
6. Rayner BL, Opie LH, Davidson JS. Primary hyperaldosteronism: How common is it in patients with severe hypertension? J Hypertens 1999; 17 (Suppl 3): S177 [P3.77].
7. Young WF, Jr. Pheochromocytoma and primary aldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am 1997; 26: 801-827.
8. Lim PO et al. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999; 353: 40.
9. Ferriss JB et al. Results of adrenal surgery in patients with hypertension, aldostorone excess, and low plasma renin concentration. Br Med J 1975; 1: 135-138.
10. Lim PO, Jung RT, MacDonald TM. Raised aldosterone to renin ratio predicts anti-hypertensive efficacy of spironolactone. A prospective cohort follow-up study. B J Clin Pharmacol 1999; 48: 756-760.
11. Hiramatsu K et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981; 141: 1589-1593.
12. McKenna TJ et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73: 952-957.
13. Gordon RD. Mineralocorticoid hypertension. Lancet 1994; 344: 240-243.
14. Jamieson A et al. Clinical, biochemical and genetic features of five extended kindred's with glucocorticoid-suppressible hyperaldosteronism. Endocr Res 1995; 21: 463-469.
15. Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales J (ed). Textbook of Hypertension. Blackwell Scientific: Oxford, 1994, pp 865-892.
16. Stowasser M, Taylor WL, Rutherford JC, Gordon RD. Diagnosis of aldosterone-producing adenoma: aldosterone/renin ratio and adrenal venous sampling. J Hypertens 1998; 16 (Suppl 2): S147.
17. Gordon RD, Hamlet SM, Tunny TJ, Klemm SA. Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis. Clin Exp Pharmocol Physiol 1987; 14: 175-179.
18. Banks WA, Kastin AJ, Biglieri EG, Ruiz AE. Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism. J Clin Endocrinol Metab 1984; 58: 783-785.
19. Vallotton MB. Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism. Clin Endocrinol 1996; 45: 47-52.
20. Weinberger MH, Fineberg NS. The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 1993; 153: 2125-2129.
21. Hamlet SM, Tunny TJ, Woodland E, Gordon RD. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol 1985; 12: 249-252.
22. Lim PO, Brennan GM, Jung RT, MacDonald TM. Diagnosing primary aldosteronism with the frusemide stimulation test. Med Biochem 1999; (in press).
23. Padfield PL, Brown JJ, Davies D, Fraser R, Lever AF, Morton JJ, Robertson JI. The myth of idiopathic hyperaldosteronism. Lancet 1981; 2: 83-84.
24. Idiopathic aldosteronism: a diagnostic artifact? Lancet 1979; 2: 1221-1222.
25. Helber A et al. Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading. Klinische Wochenschrift 1980; 58: 439-447.
26. Luetscher JA et al. Effects of sodium loading, sodium depletion and posture on plasma aldosterone concentration and renin activity in hypertensive patients. J Clin Endocrinol Metab 1969; 29: 1310-1318.
27. Weinberger MH, Dowdy AJ, Nokes GW, Luetscher JA. Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic. J Clin Endocrinol Metab 1968; 28: 359-371.
28. Collins RD et al. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Invest 1970; 49: 1415-1426.